178 related articles for article (PubMed ID: 31177486)
1. Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study.
Gallo A; Galliazzo S; Grazioli S; Guasti L; Ageno W; Squizzato A
J Thromb Thrombolysis; 2019 Aug; 48(2):336-344. PubMed ID: 31177486
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
[TBL] [Abstract][Full Text] [Related]
3. Ischemic stroke in patients receiving aspirin.
Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
[TBL] [Abstract][Full Text] [Related]
5. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
[TBL] [Abstract][Full Text] [Related]
6. Stroke occurrence while on antiplatelet therapy may predict atrial fibrillation detected after stroke.
Hsieh CY; Lee CH; Sung SF
Atherosclerosis; 2019 Apr; 283():13-18. PubMed ID: 30771556
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of mono antiplatelet therapy vs dual antiplatelet therapy in ischemic stroke or transient ischemic attack-Special subgroup consideration for the African-American Population.
Borghol A; Onor I; Neuliep A; Zaki A; Andonie G; Zaki A; Bergeron B; Castro M; Beyl R; Brakta F; Hawawini F; Ahmed F
Int J Clin Pract; 2020 Jul; 74(7):e13504. PubMed ID: 32243645
[TBL] [Abstract][Full Text] [Related]
8. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
9. Aspirin plus clopidogrel
Ye MB; Chen YL; Wang Q; An J; Ye F; Jing P
Scand Cardiovasc J; 2019 Aug; 53(4):169-175. PubMed ID: 31112048
[No Abstract] [Full Text] [Related]
10. Antiplatelet therapy in secondary ischemic stroke prevention - a short review.
Florescu C; Mustafa ER; Târtea EA; Florescu DR; Albu VC
Rom J Morphol Embryol; 2019; 60(2):383-387. PubMed ID: 31658310
[TBL] [Abstract][Full Text] [Related]
11. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy.
Horie N; Kaminogo M; Izumo T; Hayashi K; Tsujino A; Nagata I
Neurol Res; 2015 Jul; 37(7):619-23. PubMed ID: 25798683
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis.
Xiang RW; Han RB; Yang JY; Zhao MY; Zhao QC; Chen HS; Zhao FQ; Sun ZY; Zhao T; Song TY
J Neurol Sci; 2019 Apr; 399():199-206. PubMed ID: 30849580
[TBL] [Abstract][Full Text] [Related]
15. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet therapy in diabetic ischemic stroke patients: associated factors and outcomes.
Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
Int J Clin Pharmacol Ther; 2011 Oct; 49(10):605-13. PubMed ID: 21961485
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis.
Chen CY; Lee KT; Lee CT; Lai WT; Huang YB
Int J Stroke; 2014 Jul; 9(5):580-90. PubMed ID: 24597578
[TBL] [Abstract][Full Text] [Related]
18. Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China.
Su Q; Yuan K; Long F; Wan Z; Li C; Cai Y; Zeng C; Wu Y; Wu H; Liu S; Li P; Zhou J; Chen C; Wang D; Yan L; Zhang Y; Dai M
Vascular; 2014 Jun; 22(3):181-7. PubMed ID: 23929417
[TBL] [Abstract][Full Text] [Related]
19. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
20. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
